Go to Home
Go to About the Exchange
Go to Browse Innovations Exchange by Subject
QualityTools
Go to Learn & Network
Go to Resources
Go to Submit Your Innovation
Go to AHRQ Funding Opportunities
Go to FAQs
Go to Contact Us
 
< Back
QualityTool Icon QualityTool:

Guideline Recommendations for HER2 Testing in Breast Cancer: Summary Slide Set


square iconDescription

This slideshow presentation summarizes the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer.

This slideshow contains 25 slides and is organized into the following sections:

  • Introduction
  • Guideline methodology
  • Background
  • Guideline questions
  • Optimal testing algorithm for the assessment of HER2 status
  • Optimal performance, interpretation, and reporting
  • Additional ASCO/CAP resources

Links to the Tool:
This tool is available at: http://www.asco.org/ASCO/Downloads/Cancer%20Policy%20and%20Clinical%20Affai rs/Clinical%20Affairs%20(derivative%20products)/HER2%20slides%204.17.07.pdf (If you don't have the software to open this PDF, download free Adobe Acrobat Reader® software.)

Developer

American Society of Clinical Oncology; College of American Pathologists

Funding Sources

American Society of Clinical Oncology; College of American Pathologists


QualityTool Topic

Disease/Condition-Related; Guideline-Related


Links to National Guideline Clearinghouse or National Quality Measures Clearinghouse:

This tool is derived from the following guideline in the National Guideline Clearinghouse: Guideline Recommendations for HER2 Testing in Breast Cancer: Summary Slide Set:
http://www.guideline.gov/summary/summary.aspx?doc_id=10384

History

  • Release Date: 12/2006
  • Original Summary: 06/2007
Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.
QualityTool Classification
Disease/Clinical Category: spacer Breast cancer; Cancer screening; Genes, erbb-2
Patient Population: spacer Gender > Female; Vulnerable Populations > Women
Patient Care Process: spacer Preventive Care Processes > Screening; Active Care Processes: Diagnosis and Treatment > Laboratory tests; Care Management Processes > Provider-provider communication
IOM Domains of Quality: spacer Effectiveness
QualityTool Format: spacer Slide Presentation/Video/DVD
QualityTool Topic: spacer Disease/Condition-Related; Guideline-Related
Developer: spacer American Society of Clinical Oncology; College of American Pathologists
Funding Sources: spacer American Society of Clinical Oncology; College of American Pathologists

 

Last updated: April 11, 2008.

 

 spacer
 
 
AHRQ Advancing Excellence in Health Care